Peral C, Navarro F, Montoro M, Balsa A, Gomez S, Pablos J, Martinez-Sesmero JM, Valderrama M, Oyagüez I, de Andrés-Nogales F, Casado MÁ
Cost-effectiveness of tofacitinib-containing sequences for rheumatoid arthritis patients in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Marco A, Domínguez-Hernández R, Casado MA
Clinical and economic impact of the treatment of chronic hepatitis C in prison inmates in Spain
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
de Andrés-Nogales F, Oyagüez I, Morell A, Casado MÁ
Cost analysis of botulinum toxin A (Botox® and Xeomin®) in real-world clinical practice
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
García F, Domínguez-Hernández R, Alados JC, Casado M, Macías J, Téllez F, Pascasio JM, Casado MA
Healthcare outcomes of one-step diagnosis in patients with chronic hepatitis C
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Llamas-Velasco M, Sánchez-Pérez J, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Armesto S, Belinchón I, Castañeda S, Casado A, Amaro A, Yébenes M, Sabater E, COEPSO Study Group
Patient’s preferences for psoriasis treatment based on a discrete choice experiment. COEPSO study
21st Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018
Castañeda S, Vicente-Rabaneda EF, Calvo-Alén J, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Llamas-Velasco M, Casado A, Amaro A, Sabater E, Yébenes M, COEPSO Study Group